Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has provided an update.
Fidia has strengthened its capital structure through the conversion of 15 convertible POC bonds held by Global Growth Holding Limited into 1,666,666 new shares at a price of €0.90 per share. The new shares are being admitted directly to trading on the regulated market under the prospectus published earlier in February 2026.
Following this transaction, the convertible bond loan’s first tranche has been fully subscribed and converted, with no remaining subscribed but unconverted bonds. As a result, Fidia’s share capital rises by €150,000 to €10,097,761.90 and the total number of shares increases to 32,965,151, slightly diluting existing shareholders while providing the company with additional equity backing.
The completion of this conversion phase confirms investor support from GGHL and concludes the current subscribed portion of the POC financing instrument. The strengthened equity base may enhance Fidia’s financial flexibility as it pursues growth in its specialised milling and numerical control markets, potentially reinforcing its positioning in the automotive and aerospace supply chains.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in numerical control technology and high-performance integrated milling systems. With more than 40 years of experience and about 135 employees, it serves primarily the automotive mould and aerospace sectors with CNC controls, high-speed milling machines and CAM software for complex shapes.
The group differentiates itself as one of the few industrial providers able to manage the full milling workflow, from machining program definition through to the finished component. Its worldwide sales and support network underpins its positioning in niche, technologically advanced manufacturing segments, where precision and process integration are key competitive factors.
Average Trading Volume: 977,090
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.48M
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.